全球照護現場測試市場（第13版）

第 13 版「全球照護現場(POC) 市場」根據最新分析和預測，對全球 POC 診斷市場進行了分析，預測期至 2030 年。

「全球照護現場（POC）市場（第十三版）」對體外診斷（IVD）行業中最具戰略意義的細分市場之一進行了全面且前瞻性的評估。隨著醫療保健系統不斷向更快、更分散、以患者為中心的護理模式轉型，就地檢驗正從一種小眾應用轉變為臨床決策和疾病管理的重要組成部分。

本期報告反映了新冠疫情后市場發生的根本性變化。消費者即時檢測（POC​​）如今已被醫療服務提供者、保險公司和患者廣泛接受，被視為檢查室服務的重要延伸，能夠在醫院、急診室、診所、藥房以及越來越多的家庭中快速提供檢測結果。本報告探討了這種結構性轉變，以及勞動力短缺、對更快檢測結果的需求和對更密切的患者間檢驗的需求，如何推動整個產業的持續投資和創新。

即時檢測（POC​​）市場的成長受到多種因素的共同推動，包括全球慢性疾病和感染疾病負擔日益加重、人口老化、新興市場醫療保健覆蓋範圍的擴大，以及患者對便捷快速檢測的強烈需求。同時，微型化、微流體技術、生物感測器和盒式分子診斷平台的進步顯著擴展了可在中心檢查室之外進行的檢測範圍和複雜性。分子即時檢測尤其成為成長最快的領域之一，能夠在分散式環境中高靈敏度地檢測呼吸道感染疾病、性行為感染感染、醫療相關病原體和抗藥性標記。

本報告也強調了連接性和數位化整合在概念驗證 (POC) 診斷中日益成長的重要性。現代系統能夠以檢查室級的精度提供定量結果，同時與電子健康記錄、實驗室資訊系統和遠端醫療平台無縫整合。隨著診斷數據被整合到更廣泛的診療路徑中，人工智慧、臨床決策支援工具和基於雲端的數據管理預計將發揮越來越關鍵的作用。由於醫療服務提供者需要兼具分析能力、工作流程效率和合規性的解決方案，這些能力正成為製造商的關鍵差異化優勢。

本期我們將探討的另一個重要趨勢是居家檢測和藥局診斷的快速發展。在疫情期間的推動下，消費者主導的檢測方式在感染疾病、性健康和慢性病監測等領域正蓬勃發展。這種轉變迫使製造商設計更簡單、更互聯、更具臨床實用性的檢測產品，並輔以數位化工具、遠端醫療整合以及清晰的患者指導。即時檢測與遠端患者監護的融合也為糖尿病、心血管疾病和抗凝血治療管理等領域創造了新的機會。

本研究對關鍵診斷類別進行了詳細的細分，包括血糖和糖尿病監測、心臟標記、傳染病檢查、血氣和電解質分析、血液凝固檢驗尿液檢查、懷孕和不孕症檢測、癌症標記以及其他專業檢測，並提供了詳細的市場規模、成長預測和競爭分析。每個細分市場都結合了不斷發展的醫療服務模式、技術創新和報銷趨勢進行評估。

詳細分割

本報告對以下所有主要POC測試類別進行了詳細分析：

• 血液和電解質
• 癌症腫瘤標記
• 心臟標記物
• 凝血
• 結腸癌
• 濫用藥物
• 糞便潛血
• 血糖值（包括動態血糖監測和糖化血紅蛋白HbA1c）
• 感染疾病（包括 COVID-19、愛滋病毒、肝炎、性行為感染感染、呼吸道檢查、非處方藥/自測）
• 脂質
• 懷孕與不孕
• 尿
• 其他檢查（包括微生物學檢查、TSH檢查、過敏檢查、自體免疫檢查和特殊檢查）

每個類別都包括市場規模、競爭格局以及從 2025 年到 2030 年的五年預測。

調查方法

本報告涵蓋全球範圍，包括對美國、歐洲、日本和新興市場的分析，以及區域需求和醫療保健系統趨勢。報告還評估了法規結構，包括CLIA豁免途徑和國際核准流程，以及影響產品應用的報銷趨勢和證據要求。

市場估算和預測是按製造商逐一進行的，以 2025 年為基準年，預測期至 2030 年。該分析結合了第一手和第二手研究，包括對行業相關人員的訪談，並評估了醫療保健分散化、分子即時檢測的擴展、連接性需求以及向價值醫療的轉變等成長要素。

目錄

第1章：摘要整理

第2章：引言與概述

• 範圍
• 照護現場測試
• 行業法規
• CLIA認證的類型
• POC產業促進因素
• POC業
• 即時偵測 (POC) 的類型
  • 血
  • 尿
  • 唾液
  • 頭髮
  • 光學技術
  • 呼吸
• 透過即時診斷測試評估症狀
  • 癌症
  • 結腸癌
  • 攝護腺癌
  • 心血管疾病
  • 糖尿病
  • 藥物濫用
  • 感染疾病
  • 皰疹
  • HTLV
  • 呼吸道融合病毒（RSV）
  • 肝炎
  • 萊姆病
  • 焦蟲病
  • 淋病、梅毒、披衣菌感染
  • 滴蟲性陰道炎
  • 愛滋病毒/愛滋病
  • 幽門螺旋桿菌
  • 流感
  • 新冠病毒
  • 傳染性單核球增多症
  • 鏈球菌
  • 骨質疏鬆症
  • 妊娠和不孕症治療

第3章：即時血糖值檢測

• 引言和範圍
• 血糖值測試類型
  • 空腹血糖值（FBS）
  • 餐後血糖值（PPBS）
  • 隨機血糖值
  • 葡萄糖耐受試驗
  • 尿糖檢測
  • 糖化血紅素（HbA1c）
• 產品
  • 血糖值自我監測
  • 持續自檢
  • 糖化血紅素檢測
  • 專業的
• 市場規模和成長
• 區域分析
• 即時血糖自測
• POC（阻塞點）連續血糖自我監測
• POC血糖專家檢測
• 即時HbA1c檢測
• 競爭分析

第4章：即時血液和電解質檢測市場

• 引言和範圍
• 血液檢查和電解質檢查的類型
  • 血紅素/血球比容
  • 白血球和其他細胞
  • 血氣分析
  • 電解質
• 產品
• 市場規模和成長
• 區域分析
• POC血液電解質檢測套組
• 即時血液和電解質專業檢測
• 競爭分析

第5章 床邊快速凝血

• 引言和範圍
• 產品
• 血小板檢測
• 市場規模和成長
• 區域分析
• 即時快速凝血自測
• POC快速血液凝固檢驗（專業版）
• 競爭分析

第6章：床邊快速心臟標記檢測

• 引言和範圍
• 產品
• 市場規模和成長
• 區域分析
• 競爭分析

第7章：有色人種藥物濫用

• 引言和範圍
• 產品
  • 尿
  • 口腔
  • 血液
  • 頭髮
  • 尼古丁和酒精
• 市場規模和成長
• 區域分析
• POC藥物濫用自測檢測套組
• POC（藥物濫用專業檢查）
• 競爭分析

第8章：即時妊娠與不孕症檢測

• 引言和範圍
• 產品
• 市場規模和成長
• 區域分析
• POC 妊娠/生育力自測
• POC 妊娠和不孕症治療專家測試
• 競爭分析

第9章：即時大腸直腸癌篩檢/大便潛血試驗

• 引言和範圍
• 產品
• 市場規模和成長
• 區域分析
• 即時大腸直腸癌篩檢/糞便潛血隱血自測
• 即時大腸直腸癌篩檢/大便潛血試驗（專科醫師檢查）
• 競爭分析

第10章：即時傳染病檢查

• 引言和範圍
• 產品
  • 愛滋病毒和肝炎
  • 呼吸系統
  • 性行為感染傳染病
  • 熱帶病
  • 萊姆病
  • 結核
  • 茲卡病毒
  • 炭疽菌
  • 其他細菌和病毒
  • 院內感染和敗血症
  • 敗血症
  • C. difficile
• 市場規模和成長
• 區域分析
• POC感染疾病自測
• 感染發生點 (POC)感染疾病專家檢測
• 依疾病類型即時傳染病檢查
• 競爭分析

第11章 即時血脂檢測

• 引言和範圍
• 產品
• 市場規模和成長
• 區域分析
• POC血脂自測
• POC脂質專業測試
• 競爭分析

第12章：即時癌症腫瘤標記檢測

• 引言和範圍
• 產品
• 市場規模和成長
• 區域分析
• 競爭分析

第13章：即時尿液檢查

• 引言和範圍
• 產品
• 市場規模和成長
• 區域分析
• POC（阻塞點）尿液自測
• POC（阻塞點）尿液檢查- 專科檢測
• 競爭分析

第14章 其他概念驗證測試

• 引言和範圍
• 微生物學
• TSH
• 過敏
• 自體免疫
• 其他
• 其他即時檢測市場規模和成長
• POC 和其他測試銷售（按配置）
  • 區域分析

第15章：挑戰與趨勢

• 引言和範圍
• 關稅和POC行業
• 呼吸檢測的進步
• 行動醫療技術
• 遠端醫療
• 早期發現膿毒症
• 個人化醫療
• 監管障礙
• 醫療費用報銷面臨的挑戰
• PAMA
• 即時檢測與分子診斷
• 中國作為概念驗證市場
• 先進的即時檢測技術
• POC連接
• 多重即時偵測
• 新型非侵入性技術

第16章：全球即時檢測市場概況及競爭分析

• 市場概覽
• 按產品類型的市場分析
• 按子類別進行的市場分析
  • POC自測
  • POC 專業測試
• 各國市場分析
  • 美國
  • 歐洲
  • 德國
  • 法國
  • 英國（英國）
  • 瑞士
  • 其他（俄羅斯）
  • 日本
  • 其他地區
  • 拉丁美洲
  • 中國
  • 印度
  • 韓國
  • 越南和其他東南亞國家
• 競爭分析

Now in its thirteenth edition ? Worldwide Market for Point-of-Care (POC) Diagnostic Tests analyzes the global POC diagnostics market with updated insights and forecasts through 2030.

Worldwide Market for Point-of-Care (POC) Diagnostic Tests, 13th Edition delivers a comprehensive, forward-looking evaluation of one of the most strategically important segments of the in vitro diagnostics (IVD) industry. As healthcare systems continue to shift toward faster, decentralized, and patient-centered care models, point-of-care testing has moved beyond a niche role to become an essential component of clinical decision-making and disease management.

This edition reflects a market that has fundamentally evolved following the COVID-19 pandemic. POC testing is now widely accepted across providers, payers, and patients as a critical extension of laboratory services, enabling rapid results in hospitals, emergency departments, physician offices, pharmacies, and increasingly in the home. The report examines how this structural shift?combined with staffing shortages, pressure to reduce laboratory turnaround times, and demand for near-patient diagnostics?is driving sustained investment and innovation across the sector.

Growth in the POC market is being fueled by several converging forces: the rising global burden of chronic and infectious diseases, aging populations, expanding access to healthcare in emerging markets, and strong patient preference for convenient, rapid testing. At the same time, advances in miniaturization, microfluidics, biosensors, and cartridge-based molecular platforms are significantly expanding the range and complexity of tests that can be performed outside the central laboratory. Molecular point-of-care testing, in particular, is one of the fastest-growing areas, enabling highly sensitive detection of respiratory infections, sexually transmitted infections, healthcare-associated pathogens, and antimicrobial resistance markers in decentralized settings.

The report also highlights the increasing importance of connectivity and digital integration in POC diagnostics. Newer systems are delivering quantitative, lab-quality results with seamless integration into electronic health records, laboratory information systems, and remote care platforms. Artificial intelligence, clinical decision support tools, and cloud-based data management are expected to play a growing role as diagnostic data becomes more integrated into broader care pathways. These capabilities are becoming critical differentiators for manufacturers, as healthcare providers demand solutions that combine analytical performance with workflow efficiency and regulatory compliance.

Another defining trend covered in this edition is the rapid expansion of home testing and pharmacy-based diagnostics. Building on pandemic-era adoption, consumer-directed testing is gaining traction across infectious disease, sexual health, and chronic disease monitoring. This shift is pushing manufacturers to design simpler, connected, and clinically actionable tests that are supported by digital tools, telehealth integration, and clear patient guidance. The convergence of POC testing and remote patient monitoring is also creating new opportunities in areas such as diabetes, cardiovascular disease, and anticoagulation management.

The study provides in-depth segmentation across key diagnostic categories?including glucose and diabetes monitoring, cardiac markers, infectious disease testing, blood gases and electrolytes, coagulation, urinalysis, pregnancy and fertility, cancer markers, and other specialty tests?offering detailed market sizing, growth projections, and competitive analysis. Each segment is evaluated in the context of evolving care delivery models, technological innovation, and reimbursement dynamics.

Enhanced Segmentation

The report delivers detailed analysis across all major POC testing categories, including:

• Blood and Electrolytes
• Cancer Tumor Markers
• Cardiac Markers
• Coagulation
• Colon Cancer
• Drugs of Abuse
• Fecal Occult Blood
• Glucose (including CGM and HbA1c)
• Infectious Disease (including COVID-19, HIV, Hepatitis, STIs, respiratory testing, and OTC/self-testing)
• Lipid
• Pregnancy and Fertility
• Urine
• Other Testing (including microbiology, TSH, allergy, autoimmune, and specialty assays)

Each category includes market sizing, competitive positioning, and five-year forecasts 2025-2030.

Scope and Methodology

The report provides global coverage, with analysis spanning the United States, Europe, Japan, and emerging markets, along with regional demand drivers and healthcare system dynamics. It evaluates the impact of regulatory frameworks?including CLIA waiver pathways and international approval processes?as well as reimbursement trends and evidence requirements shaping adoption.

Market estimates are presented at the manufacturer level, with 2025 as the base year and forecasts through 2030. The analysis incorporates primary and secondary research, including interviews with industry stakeholders, and assesses growth drivers such as decentralization of care, expansion of molecular POC testing, connectivity requirements, and the transition toward value-based healthcare.

Table of Contents

CHAPTER 1: EXECUTIVE SUMMARY

• ABOUT KALORAMA INFORMATION
• INTRODUCTION
• SCOPE AND METHODOLOGY
• SIZE AND GROWTH OF THE MARKET
  • Table 1-1: Global POC Test Market, 2025-2030 (US$ millions, manufacturer level)
  • Figure 1-1: Global POC Test Market, 2025-2030 (US$ millions, manufacturer level)
• TRENDS AFFECTING THE MARKET
• COMPETITIVE OUTLOOK
• CONCLUSIONS
  • Conclusion One: Tariffs Affecting the POC Market
  • Conclusion Two: Rapid Molecular POC Tests Growing
  • Conclusion Three: Multiplex Expansion Beyond COVID and Flu
  • Conclusion Four: Reimbursement Issues Still Loom
  • Conclusion Five: PAMA Affects POC Adoption
  • Conclusion Six: China’s Volume-Based Procurement Putting Pressure on POC Companies

CHAPTER 2: INTRODUCTION AND OVERVIEW

• SCOPE
• POINT-OF-CARE DIAGNOSTICS TESTING
• INDUSTRY REGULATIONS
• TYPES OF CLIA CERTIFICATES
• POC INDUSTRY DRIVERS
  • Patient-focused drivers
  • Medical/Healthcare-related drivers
  • Technology drivers
  • Economic drivers
  • Other drivers
• POC INDUSTRY CHALLENGES
• POC TEST TYPES
  • Blood
  • Urine
  • Saliva
  • Hair
  • Optical Technologies
  • Breath
• CONDITIONS EVALUATED BY POC DIAGNOSTIC TESTING
  • Cancer
  • Colorectal Cancer
  • Prostate Cancer
  • Cardiovascular Disease
  • Diabetes
  • Drug Abuse
  • Infectious Disease
  • Herpes
  • HTLV
  • Respiratory Syncytial Virus
  • Hepatitis
  • Lyme Disease
  • Babesiosis
  • Gonorrhea, Syphilis and Chlamydia
  • Trichomonas Vaginalis
  • HIV/AIDS
  • Helicobacter Pylori
  • Influenza
  • Coronavirus
  • Mononucleosis
  • Streptococcus
  • Osteoporosis
  • Pregnancy and Fertility

CHAPTER 3: POC BLOOD GLUCOSE TESTS

• INTRODUCTION AND SCOPE
• TYPES OF BLOOD GLUCOSE TESTING
  • Fasting Blood Sugar (FBS)
  • 2-Hour Postprandial Blood Sugar (PPBS)
  • Random Blood Sugar
  • Glucose Tolerance Test
  • Glucose Urine Test
  • Glycated Hemoglobin (HbA1c)
• PRODUCTS
  • Blood Glucose Self-Testing
    • Table 3-1: Selected Glucose Self-Test Meter Innovations
    • Table 3-2: Selected Apps and Glucose Management IT
  • Continuous Self-Testing
  • Glycated Hemoglobin Tests
    • Table 3-3: Selected POC HbA1c Testing Systems and Related Products
  • Professional
• MARKET SIZE AND GROWTH
  • Table 3-4: Global POC Glucose (including CGM and HbA1c) Testing Market Analysis, 2025-2030 (US$ millions, manufacturer level)
  • Figure 3-1: Global POC Glucose (including CGM and HbA1c) Testing Market Analysis, 2025-2030 (US$ millions, manufacturer level)
  • Table 3-5: Global POC Diabetes Sales, by Test Category, 2025-2030 ($ million) [Glucose, Continuous; Glucose, Professional; Glucose, Self-test; HbA1c, POC]
• Regional Analysis
  • Figure 3-2: POC Blood Glucose Testing Regional Market Analysis, 2025 (%)
• POC Glucose Self-Testing
  • Table 3-6: Global POC Glucose Self-Testing Market (excludes continuous glucose devices), 2025-2030 (US$ millions, manufacturer level)
• POC Continuous Glucose Self-Testing
  • Table 3-7: Global POC Continuous Glucose Self-Testing Market, 2025-2030 (US$ millions, manufacturer level)
• POC Glucose Professional Testing
  • Table 3-8: Global POC Glucose Professional Testing Market (excludes HbA1c testing), 2025-2030 (US$ millions, manufacturer level)
• POC HbA1c Testing
  • Table 3-9: Global POC Glucose HbA1c Professional Testing Market 2025-2030 (US$ millions, manufacturer level)
• COMPETITIVE ANALYSIS
  • Table 3-10: Global POC Blood Glucose Testing Market (BGM, CGM, HbA1c), Revenues and Market Share of Leading Suppliers, 2025 (US$ millions)
  • Figure 3-3: Global POC Glucose Test Manufacturers, Market Share of Leading Suppliers, 2025 (%)

CHAPTER 4: POC BLOOD AND ELECTROLYTES TESTING MARKET

• INTRODUCTION AND SCOPE
• TYPES OF BLOOD AND ELECTROLYTES TESTS
  • Hemoglobin/Hematocrit
  • WBC and Other
  • Blood Gases
  • Electrolytes
• PRODUCTS
  • Table 4-1: Selected POC Hemoglobin and Hematocrit Systems, 2025
  • Table 4-2: Selected POC Hematology Analyzer Systems, 2025
• MARKET SIZE AND GROWTH
  • Table 4-3: Global POC Blood and Electrolytes Testing Market* Analysis, 2025-2030 (US$ millions, manufacturer level)
  • Figure 4-1: Global POC Blood and Electrolytes Testing Market Analysis, 2025-2030 (US$ millions, manufacturer level)
  • Table 4-4: Global POC Blood & Electrolytes Revenues, by Test Category, 2025-2030 (US$ millions)
• Regional Analysis
  • Figure 4-2: POC Blood and Electrolytes Testing Regional Market Analysis, 2025 (%)
• POC Blood and Electrolyte Self-Testing
  • Table 4-5: Global POC Blood and Electrolyte Self-Testing Market Analysis, 2025-2030 (US$ millions, manufacturer level)
• POC Blood and Electrolyte Professional Testing
  • Table 4-6: Global POC Blood and Electrolyte Professional Testing Market Analysis, 2025-2030 (US$ millions, manufacturer level)
• COMPETITIVE ANALYSIS
  • Table 4-7: Global POC Blood and Electrolyte Testing Market, Revenues and Market Share of Leading Suppliers, 2025 (US$ millions)
  • Figure 4-3: Global POC Blood and Electrolyte Testing Market Manufacturers, Market Share of Leading Suppliers, 2025 (%)

CHAPTER 5: POC RAPID COAGULATION

• INTRODUCTION AND SCOPE
• PRODUCTS
  • Table 5-1: Selected POC Coagulation Test Innovations
• Platelet Testing
  • Table 5-2: Selected Platelet Activity Test Innovations
• MARKET SIZE AND GROWTH
  • Table 5-3: Global Rapid Coagulation Testing Market Analysis, 2025-2030 (US$ millions, manufacturer level)
  • Figure 5-1: Global Rapid Coagulation Testing Market Analysis, 2025-2030 (US$ millions, manufacturer level)
• Regional Analysis
  • Figure 5-2: POC Rapid Coagulation Testing Regional Market Analysis, 2025 (%)
• POC Rapid Coagulation Self-Testing
  • Table 5-4: POC Rapid Coagulation Self-Testing, Market Analysis, 2025-2030 (US$ millions, manufacturer level)
• POC Rapid Coagulation Professional Testing
  • Table 5-5: POC Rapid Coagulation Professional Testing Market Analysis, 2025-2030 (US$ millions, manufacturer level)
• COMPETITIVE ANALYSIS
  • Table 5-6: Global POC Rapid Coagulation Testing Market, Revenues and Market Share of Leading Suppliers, 2025 (US$ millions)
  • Figure 5-3: Global POC Rapid Coagulation Testing Market, Market Share of Leading Suppliers, 2025 (%)

CHAPTER 6: POC RAPID CARDIAC MARKERS

• INTRODUCTION AND SCOPE
• PRODUCTS
• MARKET SIZE AND GROWTH
  • Table 6-1: Total Rapid Total Rapid Cardiac Marker Test Market Analysis, 2025-2030 (US$ millions, manufacturer level)
  • Figure 6-1: Total POC Rapid Cardiac Marker Test Market Analysis, 2025-2030 (US$ millions, manufacturer level)
• Regional Analysis
  • Figure 6-2: POC Rapid Cardiac Markers Testing Regional Market Analysis, 2025 (%)
• COMPETITIVE ANALYSIS
  • Table 6-2: Global POC Cardiac Markers Test Market, Revenues and Market Share of Leading Suppliers, 2025 (US$ millions)
  • Figure 6-3: Global POC Cardiac Markers Test Manufacturers, 2025 (%)

CHAPTER 7: POC SUBSTANCE ABUSE

• INTRODUCTION AND SCOPE
• PRODUCTS
  • Urine
  • Oral
  • Blood-based
  • Hair
  • Nicotine and Alcohol
• MARKET SIZE AND GROWTH
  • Table 7-1: Global POC Drugs-of-Abuse Testing* Market Analysis, 2025-2030 (US$ millions, manufacturer level)
  • Figure 7-1: Global POC Drugs-of-Abuse Testing Market Analysis, 2025-2030 (US$ millions, manufacturer level)
• Regional Analysis
  • Figure 7-2: POC Substance Abuse Testing Regional Market Analysis, 2025 (%)
• POC Drugs of Abuse Self-Testing
  • Table 7-2: Global POC Drugs of Abuse Self-Testing Market, 2025-2030 (US$ millions, manufacturer level)
• POC Drugs of Abuse Professional Testing
  • Table 7-3: Global POC Drugs of Abuse Professional Testing Market Analysis, 2025-2030 (US$ millions, manufacturer level)
• COMPETITIVE ANALYSIS
  • Table 7-4: Global POC Drugs of Abuse Testing Market, Revenues and Market Share of Leading Suppliers, 2025 (US$ millions)
  • Figure 7-3: Global POC Drug of Abuse Testing Manufacturers, 2025 (%)

CHAPTER 8: POC PREGNANCY AND FERTILITY TESTING

• INTRODUCTION AND SCOPE
• PRODUCTS
  • Table 8-1: Selected Pregnancy and Fertility CLIA-Waived Instruments, Devices, and Assays
• MARKET SIZE AND GROWTH
  • Table 8-2: Global POC Pregnancy and Fertility Testing Market Analysis, 2025-2030 (US$ millions, manufacturer level)
  • Figure 8-1: Global POC Pregnancy and Fertility Testing Market Analysis, 2025-2030 (US$ millions, manufacturer level)
• Regional Analysis
  • Figure 8-2: POC Pregnancy and Fertility Testing Regional Market Analysis, 2025 (%)
• POC Pregnancy and Fertility Self-Testing
  • Table 8-3: POC Pregnancy and Fertility Self-Testing Market Analysis, 2025-2030 (US$ millions, manufacturer level)
• POC Pregnancy and Fertility Professional Testing
  • Table 8-4: POC Pregnancy and Fertility Professional Testing Market Analysis, 2025-2030 (US$ millions, manufacturer level)
• COMPETITIVE ANALYSIS
  • Table 8-5: Global POC Pregnancy and Fertility Testing Market, Revenues and Market Share of Leading Suppliers, 2025 (US$ millions)
  • Figure 8-3: Global POC Pregnancy and Fertility Testing Manufacturers, 2025 (%)

CHAPTER 9: POC COLON CANCER SCREENING/FECAL OCCULT BLOOD TESTING

• INTRODUCTION AND SCOPE
• PRODUCTS
  • Table 9-1: Selected POC and Home-Based Colon Cancer Screening Tests
• MARKET SIZE AND GROWTH
  • Table 9-2: Global POC Colon Cancer Screening/Fecal Occult Blood Testing Market Analysis, 2025-2030 (US$ millions, manufacturer level)
  • Figure 9-1: Global POC Colon Cancer Screening/Fecal Occult Blood Testing Market Analysis, 2025-2030 (US$ millions, manufacturer level)
• Regional Analysis
  • Figure 9-2: POC Colon Cancer Screening/FOB Testing Regional Market Analysis, 2025 (%)
• POC Colon Cancer Screening/Fecal Occult Blood Self-Testing
  • Table 9-3: POC Colon Cancer Screening/Fecal Occult Blood Self-Testing Market Analysis, 2025-2030 (US$ millions, manufacturer level)
• POC Colon Cancer Screening/Fecal Occult Blood Professional Testing
  • Table 9-4: POC Colon Cancer Screening/Fecal Occult Blood Professional Testing Market Analysis, 2025-2030 (US$ millions, manufacturer level)
• COMPETITIVE ANALYSIS
  • Table 9-5: Global POC Colon Cancer Screening/Fecal Occult Blood Testing Market, Revenues and Market Share of Leading Suppliers, 2025 (US$ millions)
  • Figure 9-3: Global POC Colon Cancer Screening/Fecal Occult Blood Testing Manufacturers, 2025 (%)

CHAPTER 10: POC INFECTIOUS DISEASE TESTING

• INTRODUCTION AND SCOPE
• PRODUCTS
  • HIV and Hepatitis
  • Respiratory
  • STD/STI
  • Tropical Diseases
  • Lyme Disease
  • TB
  • Zika
  • Anthrax
  • Other Bacteria and Viruses
  • Hospital Acquired Infections and Sepsis
  • Sepsis
  • C. difficile
    • Table 10-1: Selected Innovations in POC Infectious Disease Diagnostics
• MARKET SIZE AND GROWTH
  • Table 10-2: Global POC Infectious Disease (including COVID-19) Testing Market Analysis, 2025-2030 (US$ millions, manufacturer level)
  • Figure 10-1: Global POC Infectious Disease (including COVID-19) Testing Market Analysis, 2025-2030 (US$ millions, manufacturer level)
• Regional Analysis
  • Figure 10-2: POC Infectious Disease (including COVID-19) Testing Regional Market Analysis, 2025 (%)
• POC Infectious Disease Self-Testing
  • Table 10-3: POC Infectious Disease Self-Testing (including COVID-19) Market Analysis, 2025-2030 (US$ millions, manufacturer level)
• POC Infectious Disease Professional Testing
  • Table 10-4: POC Infectious Disease Professional Testing (including COVID-19) Market Analysis, 2025-2030 (US$ millions, manufacturer level)
• POC Infectious Disease Testing by Disease Type
  • Table 10-5: Global POC Infectious Disease Revenues and Percent of Infectious Disease Market, by Disease Type, 2025 (US$ millions) [C. difficile, E. coli, H. pylori, Hepatitis, HIV, Home Test/OTC, Malaria, Respiratory, STD, Others]
• COMPETITIVE ANALYSIS
  • Table 10-6: Global POC Infectious Disease, including COVID-19 Testing Market, Revenues and Market Share of Leading Suppliers, 2025 (US$ millions)
  • Figure 10-3: Global POC Infectious Disease Test Manufacturers, 2025 (%)

CHAPTER 11: POC LIPID TESTING

• INTRODUCTION AND SCOPE
• PRODUCTS
• MARKET SIZE AND GROWTH
  • Table 11-1: Global POC Lipid Testing Market Analysis, 2025-2030 (US$ millions, manufacturer level)
  • Figure 11-1: Global POC Lipid Testing Market Analysis, 2025-2030 (US$ millions, manufacturer level)
• Regional Analysis
  • Figure 11-2: POC Lipid Testing Regional Market Analysis, 2025 (%)
• POC Lipid Self-Testing
  • Table 11-2: POC Lipid Self-Testing Market Analysis, 2025-2030 (US$ millions, manufacturer level)
• POC Lipid Professional Testing
  • Table 11-3: POC Lipid Professional Testing Market Analysis, 2025-2030 (US$ millions, manufacturer level)
• COMPETITIVE ANALYSIS
  • Table 11-4: Global POC Lipid Testing Market, Revenues and Market Share of Leading Suppliers, 2025 (US$ millions)
  • Figure 11-3: Global POC Lipid Testing Manufacturers, 2025 (%)

CHAPTER 12: POC CANCER TUMOR MARKER TESTING

• INTRODUCTION AND SCOPE
• PRODUCTS
  • Table 12-1: Selected Companies Developing and/or Marketing POC Tests for Oncology Indications
• MARKET SIZE AND GROWTH
  • Table 12-2: Global POC Cancer Testing Market Analysis, 2025-2030 (US$ millions, manufacturer level)
  • Figure 12-1: Global POC Cancer Testing Market Analysis, 2025-2030 (US$ millions, manufacturer level)
• Regional Analysis
  • Figure 12-2: POC Cancer Tumor Marker Testing Regional Market Analysis, 2025 (%)
• COMPETITIVE ANALYSIS
  • Table 12-3: Global POC Cancer Testing Market, Revenues and Market Share of Leading Suppliers, 2025 (US$ millions)
  • Figure 12-3: Global POC Cancer Testing Manufacturers, 2025 (%)

CHAPTER 13: POC URINE TESTING

• INTRODUCTION AND SCOPE
• PRODUCTS
• MARKET SIZE AND GROWTH
  • Table 13-1: Global POC Urine Testing Market Analysis, 2025-2030 (US$ millions, manufacturer level)
  • Figure 13-1: Global POC Urine Testing Market Analysis, 2025-2030 (US$ millions, manufacturer level)
• Regional Analysis
  • Figure 13-2: POC Urine Testing Regional Market Analysis, 2025 (%)
• POC Urine Self-Testing
  • Table 13-2: POC Urine Self-Testing Market Analysis, 2025-2030 (US$ millions, manufacturer level)
• POC Urine Test Professional Testing
  • Table 13-3: POC Urine Professional Testing Market Analysis, 2025-2030 (US$ millions, manufacturer level)
• COMPETITIVE ANALYSIS
  • Table 13-4: Global POC Urine Testing Market, Revenues and Market Share of Leading Suppliers, 2025 (US$ millions)
  • Figure 13-3: Global POC Urine Strip Testing Manufacturers, 2025 (%)

CHAPTER 14: MISCELLANEOUS POC TESTING

• INTRODUCTION AND SCOPE
• MICROBIOLOGY
  • Table 14-1: Global POC Microbiology Test Sales, 2025-2030 (US$ millions)
• TSH
  • Table 14-2: Global POC Thyroid-Stimulating Hormone (TSH) Test Sales, 2025-2030 (US$ millions)
• ALLERGY
  • Table 14-3: Global POC Allergy Test Sales, 2025-2030 (US$ millions)
• AUTOIMMUNE
  • Table 14-4: Global POC Autoimmune Test Sales, 2025-2030 (US$ millions)
• OTHERS
  • Table 14-5: Global POC Other Test Sales, 2025-2030 (US$ millions)
• MISCELLANEOUS POC TESTING MARKET SIZE AND GROWTH
  • Table 14-6: Global Miscellaneous POC Testing Market Analysis, 2025-2030 (US$ millions, manufacturer level)
  • Figure 14-1: Global Miscellaneous POC Testing Market Analysis, 2025-2030 (US$ millions, manufacturer level)
  • Table 14-7: Global POC Miscellaneous Sales, by Test Category, 2025-2030 (US$ millions) [Allergy, Autoimmune, Microbiology, TSH, Others]
• POC Miscellaneous Test Sales by Setting
  • Table 14-8: POC Miscellaneous Test Sales by Setting 2025-2030 ($millions)
  • Regional Analysis
  • Figure 14-2: POC Miscellaneous Testing Regional Market Analysis, 2025 (%)

CHAPTER 15: ISSUES AND TRENDS

• INTRODUCTION AND SCOPE
• TARIFFS AND THE POC INDUSTRY
• BREATH TEST ADVANCES
  • Table 15-1: Selected Disease Markers in Exhaled Breath
• MOBILE HEALTHCARE TECHNOLOGIES
• TELEHEALTH
• EARLY SEPSIS DETECTION
• PERSONALIZED MEDICINE
• REGULATORY HURDLES
• REIMBURSEMENT CHALLENGES
• PAMA
• POC AND MOLECULAR DIAGNOSTICS
  • Table 15-2: Selected Market Available Molecular POC Diagnostic Platforms
• CHINA AS A POC MARKET
• ADVANCING POC TECHNOLOGIES
• POC CONNECTIVITY
• MULTIPLEXED POC TESTING
• EMERGING NON-INVASIVE TECHNOLOGIES
  • Saliva and Swab
  • Optical Techniques
  • Volatolomics
  • POC AND ANTIMICROBIAL STEWARDSHIP
  • ARTIFICIAL INTELLIGENCE IN POC
  • HYBRID EMERGENCY DEPARTMENT /URGENT CARE CENTERS AND POC
  • DIGITAL DIAGNOSTICS
  • MICROFLUIDICS AND POC

CHAPTER 16: TOTAL GLOBAL POC TESTING MARKET AND COMPETITOR ANALYSIS

• MARKET OVERVIEW
  • Table 16-1: Global POC Test Market, 2025-2030 (US$ millions, manufacturer level)
  • Figure 16-1: Global POC Test Market, 2025-2030 (US$ millions, manufacturer level)
• MARKET ANALYSIS BY PRODUCT CATEGORIES
  • Table 16-2: Global POC Testing Market Analysis, by Product Category, 2025 (US$ millions) [Professional Testing, Self-Testing]
• MARKET ANALYSIS BY SUBCATEGORY
  • POC Self-Testing
    • Table 16-3: Global POC Self-Testing Market Analysis, by Product Category, 2025 (US$ millions) [Blood & Electrolytes, Coagulation, Drugs of Abuse, Fecal Occult Blood, Glucose (includes CGM), Infectious Disease, Lipid, Pregnancy & Fertility, Urine, Miscellaneous]
    • Figure 16-2: Global POC Self-Testing Market Analysis, by Product Category, 2025 (%) [Blood & Electrolytes, Coagulation, Drugs of Abuse, Fecal Occult Blood, Glucose (includes CGM), Infectious Disease, Lipid, Pregnancy & Fertility, Urine, Miscellaneous]
  • POC Professional Testing
    • Table 16-4: Global POC Professional Testing Market Analysis, by Product Subcategory, 2025 (US$ millions) [Blood & Electrolytes, Cardiac Markers, Cancer Tumor Markers, Drugs of Abuse, Fecal Occult Blood, Glucose includes HbA1c, Infectious Disease, Lipid, Pregnancy & Fertility, Rapid Coagulation, Urine, Miscellaneous]
    • Figure 16-3: Global POC Professional Testing Market Analysis, by Product Subcategory, 2025 (%) [Blood & Electrolytes, Cardiac Markers, Cancer Tumor Markers, Drugs of Abuse, Fecal Occult Blood, Glucose includes HbA1c, Infectious Disease, Lipid, Pregnancy & Fertility, Rapid Coagulation, Urine, Miscellaneous]
• MARKET ANALYSIS BY COUNTRY
  • United States
    • Table 16-5: US POC Testing Market Analysis, 2025-2030 (US$ millions, manufacturer level)
  • Europe
    • Table 16-6: Europe POC Testing Market Analysis, 2025-2030 (US$ millions, manufacturer level)
  • Germany
  • France
  • United Kingdom (UK)
  • Switzerland
  • Other (Russia)
    • Figure 16-4: European POC Testing Market Share, by Country, 2025 (%)
  • Japan
    • Table 16-7: Japan POC Testing Market Analysis, 2025-2030 (US$ millions, manufacturer level)
  • Rest of World
  • Latin America
  • China
  • India
  • South Korea
  • Vietnam and Other Southeast Asia
    • Table 16-8: Global POC Testing Market Analysis, by Rest of World Region/Country, 2025 (US$ millions) [Australia; China; India; Latin America, Middle East and Canada; South Korea and other Asian countries; Other]
    • Figure 16-5: Rest of World POC Testing Market Share, by Country, 2025 (%) [Australia, China, India, Latin America, South Korea, Other]
    • Table 16-9: Global POC Testing Analysis, by Region/Country, 2025 (US$ millions)
    • Figure 16-6: Global POC Testing Market Analysis, Market Share by Region/Country, 2025 (%)
• COMPETITIVE ANALYSIS
  • Table 16-10: Global Top POC Testing Market Revenues and Market Share of Leading Suppliers, 2025 (US$ millions)
  • Figure 16-7: Global POC Testing Market Share, by Leading Suppliers, 2025 (%)